These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7471340)

  • 1. Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.
    Siegel LA; Keung E; Siskind SJ; Forman R; Feinberg H; Strom J; Efstathakis D; Sonnenblick EH; LeJemtel TH
    Circulation; 1981 Apr; 63(4):838-44. PubMed ID: 7471340
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and regional blood flow distribution responses to dextran, hydralazine, isoproterenol and amrinone during experimental cardiac tamponade.
    Millard RW; Fowler NO; Gabel M
    J Am Coll Cardiol; 1983 Jun; 1(6):1461-70. PubMed ID: 6189872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative vasoactive therapy for heart failure.
    Benotti JR; McCue JE; Alpert JS
    Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.
    Siskind SJ; Sonnenblick EH; Forman R; Scheuer J; LeJemtel TH
    Circulation; 1981 Nov; 64(5):966-73. PubMed ID: 7285310
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
    LeJemtel TH; Keung E; Ribner HS; Davis R; Wexler J; Blaufox JD; Sonnenblick EH
    Am J Cardiol; 1980 Jan; 45(1):123-9. PubMed ID: 7350759
    [No Abstract]   [Full Text] [Related]  

  • 6. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
    LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
    Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
    [No Abstract]   [Full Text] [Related]  

  • 10. Amrinone in the management of low cardiac output after open heart surgery.
    Goenen M; Pedemonte O; Baele P; Col J
    Am J Cardiol; 1985 Jul; 56(3):33B-38B. PubMed ID: 4025158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
    Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA
    Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
    Drexler H; Löllgen H; Just H
    Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR; Grossman W; Braunwald E; Carabello BA
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amrinone in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS; Sutton MS; Wilson H; Rocci ML
    J Am Coll Cardiol; 1984 May; 3(5):1282-90. PubMed ID: 6707381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
    Rich S; Ganz R; Levy PS
    Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS; Forman R; Klein NA; Sonnenblick EH; LeJemtel TH
    Am J Med; 1982 Jan; 72(1):113-8. PubMed ID: 7058816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA; Canter JM; Fort DJ
    Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.